1. Åblad, B., Johnsson, G., Norrby, A., Sölvell, L.: Potency and time-effect relationship in man of propranolol and H 56/28 ? comparative studies after oral administration. Acta Pharmacol. et Toxicol.25, Suppl. 2, 85?94 (1967).
2. -- Ervik, M., Hallgren, J., Johnsson, G., Sölvell, L.: Pharmacological effects and plasma levels of orally administered alprenolol in man. To be published 1971.
3. Björntorp, P.: Treatment of angina pectoris with beta-receptor blocking agents. Effects of long-term treatment and treatment with sustained release tablets. Acta Med. In press.
4. Dollery, C.T., Paterson, J.Kl., Conelly, M.E.: Clinical pharmacology of beta-receptor blocking drugs. Clin. pharmacol. Ther.10, 765?769 (1969).
5. Ervik, M.: Gas chromatographic determination of the secondary amine alprenolol, as its trifluoroacetyl derivative, at nanogram levels in biological fluids. Acta Pharm. Suecica6, 393?400 (1969).